Articles Tagged with Gene Esplin

shutterstock_186555158-300x200Advisor Gene Esplin (Esplin), formerly employed by Kalos Capital, Inc. (Kalos) and Triad Advisors, Inc. (Triad Advisors) has been subject to at least one customer complaint during the course of his career.  According to a BrokerCheck report one of the customer complaint concerns alternative investments such as direct participation products (DPPs) like business development companies (BDCs), non-traded real estate investment trusts (REITs), oil & gas programs, annuities, and private placements.  The attorneys at Gana Weinstein LLP have represented hundreds of investors who suffered losses caused by these types of high risk, low reward products.

In December 2019 a customer complained that Esplin violated the securities laws by alleging that Esplin engaged in sales practice violations related to allegations that alternative investments purchased at Triad during the Representative’s association with respondent Triad and thereafter during the Representative’s association with respondent Kalos Capital were unsuitable.  The claim alleges $1,000,000 and is currently pending.

DDPs include products such as non-traded REITs, oil and gas offerings, equipment leasing products, and other alternative investments.  These alternative investments virtually never profit investors and are almost always unsuitable for investors because of their high fee and cost structure.  Brokers selling these products are paid additional commission in order to hype these inferior quality investments providing a perverse incentives to create an artificial market for the investments.

Several studies have confirmed that Non-traded REITs underperform publicly traded REITs with some showing that Non-Traded REITs cannot even beat safe benchmarks, like U.S. treasury bonds.  Brokers selling these products must disclose to the investor that non-traded REITs provide lower investment returns than treasuries while being high risk and illiquid – but almost never do.  Because investors are not compensated with additional return in exchange for higher risk and illiquidity, these kinds of alternative investment products are rarely, if ever, appropriate for investors.  Continue Reading

Contact Information